Details of the Drug

General Information of Drug (ID: DM0QTUW)

• Drug Name: DFV890

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]

• Drug Type: Protein/peptide drug
• Cross-matching ID:
  PubChem CID: 172011805
  TTD ID: D05FGN

References

• [1] ClinicalTrials.gov (NCT04382053) Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia. U.S. National Institutes of Health.